Clinical Trials

Showing trials with last updates posted in 2026.

NCT07779798 | NOT_YET_RECRUITING | PHASE1
120 participants

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-21
Start Date:
2026-08-31
Completion:
2028-01-31
Conditions
  • Advanced Solid Tumors
  • Recurrent or Progressive Glioblastoma
  • Relapse or Refractory Myeloid Malignancies
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page